Local
injections of botulinum toxin may significantly benefit patients
with spasticity, dystonia, torticollis, hemifacial spasm, blepharospasm,
meige syndrome, spastic dysphonia, writer cramp, hyperhydrosis,
or tremor
South Shore
Neurologic Associates BOTOX® Treatment Program offers extensive
experience in the use of BOTOX® for spasticity, dystonia, tremor
and many other movement disorders, as well as for hyperhydrosis.
Current
Indications
In the USA, the FDA has
approved BOTOX® "for treatment of strabismus and blepharospasm
associated with dystonia, including benign essential blepharospasm
of VII nerve disorders in patients 12 years of age and above"
Use in other conditions
considered "extra-label use" if the indication is "accepted
as safe and effective" e,g.: spasticity, cervical dystonia,
spasmodic dysphonia, writer's cramp, tremor.
NIH Consensus
Statement 1990
Proper choice of the
dose and of the administration site are the most important determinants
of a favorable response to BTX treatment
Clinical effects are
typically seen within 1 week of injection
Benefits typically last
between 3 - 6 months
The safety, effectiveness,
specificity, and reversibility of BTX therapy make it an extremely
useful therapy
general
facts
patient selection
goal
setting
treatment
dosing
adverse
effects
faq
NIH Consensus
Statement
Information contained in
this web site was obtained from many sources including:
We Move slide library
We Move Web site
Muscle & Nerve
Supplement 9/6/97 on Spasticity
lecture notes from
Dr. David Simpson
Dr. Melinda Morrissey
Allergen
Numerous other web
sites.
Mark Gudesblatt M.D.
South Shore Neurologic
Associates, Bay Shore, N.Y.
